ketanserin has been researched along with 3,4-dihydroxyphenylacetic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilcox, RE; Young, KA | 1 |
| Nash, JF | 1 |
| Mistry, A; Voogt, JL | 1 |
| Eens, A; Gommeren, W; Janssen, PA; Leysen, JE; Van Gompel, P; Wynants, J | 1 |
| Liang, SL; Pan, JT | 1 |
| Basura, GJ; Walker, PD | 1 |
| Cho, Y; Choi, HJ; Hwang, O; Lee, SY | 1 |
7 other study(ies) available for ketanserin and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Characterization of D2 receptors and dopamine levels in the thalamus of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Homovanillic Acid; Ketanserin; Kinetics; Male; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Spiperone; Synaptic Transmission; Thalamus | 1991 |
Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Ketanserin; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1990 |
Role of serotonin in nocturnal and diurnal surges of prolactin in the pregnant rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Circadian Rhythm; Dopamine; Ergolines; Female; Fenclonine; Hydroxyindoleacetic Acid; Hypothalamus; Ketanserin; Pregnancy; Pregnancy, Animal; Prolactin; Rats; Rats, Inbred Strains; Serotonin | 1989 |
Non-serotonergic [3H]ketanserin binding sites in striatal membranes are associated with a dopac release system on dopaminergic nerve endings.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding Sites; Corpus Striatum; Dopamine; In Vitro Techniques; Ketanserin; Nerve Endings; Phenylacetates; Rats | 1987 |
An endogenous serotonergic rhythm acting on 5-HT(2A) receptors may be involved in the diurnal changes in tuberoinfundibular dopaminergic neuronal activity and prolactin secretion in female rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Circadian Rhythm; Dihydroxyphenylalanine; Dopamine; Estrogens; Female; Ketanserin; Nerve Degeneration; Neurons; Ovariectomy; Pituitary Gland; Prolactin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2000 |
Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Enkephalins; Gene Expression Regulation; Hydroxyindoleacetic Acid; In Situ Hybridization; Ketanserin; Male; Neurons; Oxidopamine; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sympatholytics; Tachykinins; Transcription, Genetic | 2001 |
Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Benzoquinones; Biopterins; Cell Death; Cell Line; Cytosol; Dimethyl Fumarate; Dopamine; Drug Resistance; Enzyme Inhibitors; Fumarates; Ketanserin; Lipid Peroxidation; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Mice; Monoamine Oxidase Inhibitors; Neurons; Oxidative Stress; Parkinson Disease; Substantia Nigra; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2005 |